![Leon Hooftman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leon Hooftman
Chief Tech/Sci/R&D Officer at
BARINTHUS BIOTHERAPEUTICS PLC
Net worth: - $ as of 30/07/2026
Profile
Leon Hooftman currently works at Barinthus Biotherapeutics Plc, as Chief Medical Officer from 2024.
Dr. Hooftman also formerly worked at Hoffmann-La Roche, Inc., as Director-Clinical Science, Celltech Group Plc, as Head-Clinical Development, Chroma Therapeutics Ltd., as Chief Medical Officer, Syntex, Inc., as Senior Clinical Research Physician, Opsona Therapeutics Ltd., as Chief Medical Officer, and DCPrime BV, as Member-Supervisory Board.
Dr. Hooftman received his undergraduate degree from the University of Utrecht and doctorate degree in 1984 from the University of Utrecht.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2026 | 0 ( -.--% ) | - $ | 30/07/2026 |
Leon Hooftman active positions
| Companies | Position | Start |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 31/05/2024 |
Former positions of Leon Hooftman
| Companies | Position | End |
|---|---|---|
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Director/Board Member | - |
Syntex, Inc.
 Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Chief Tech/Sci/R&D Officer | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Training of Leon Hooftman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
- Stock Market
- Insiders
- Leon Hooftman
